This trial is active, not recruiting.

Condition cardiac health
Treatment questionnaire
Sponsor Memorial Sloan Kettering Cancer Center
Start date November 2011
End date November 2017
Trial size 200 participants
Trial identifier NCT01474577, 11-150


The physician would like to see if nuclear cardiac stress tests can predict cardiac health. For example, if a patient has an abnormal stress test, is he or she more likely to have cardiac problems in the future?

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model cohort
Time perspective retrospective
Eligible patients will have had Rb-82 PET myocardial perfusion imaging at MSKCC, 2008 - 2011. Patients will complete one questionnaire over the phone.
Patients will complete one questionnaire over the phone. We will ask patients to describe their cardiac history since Rb-82 PET (chest pain, shortness of breath, cardiac catheterization, and heart attack). This information will be correlated to the scan results and other relevant information in the patient's medical record.

Primary Outcomes

correlate scan findings with clinical outcomes
time frame: 1 year

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Patient > or = to 18 years of age - Registered patient at MSKCC - Patient with one or more 82Rb myocardial perfusion stress tests performed at MSKCC, 2008—2011 Exclusion Criteria: - Patient is unwilling to participate

Additional Information

Principal investigator Heiko Schöder, MD
Trial information was received from ClinicalTrials.gov and was last updated in November 2016.
Information provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center.